The Effect of Self-Forgiveness on Self-Stigma in Addiction.

NCT03971097 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2021-09-05

No results posted yet for this study

Summary

This study has an experimental design and will examine the difference in pre-test and post-test data on the Self-Forgiveness Dual Process Scale (SFDPS) (Griffin, Worthington, Davis, Hook, \& Maguen, 2018) and the Substance Abuse Self-Stigma Scale (SASSS) (Luoma et al., 2013). Data will be collected from two groups of participants receiving counseling at the short-term rehabilitation facility located at University of Pittsburgh Medical Center's (UPMC). Individuals who agree to participate in the study will be randomly assigned to either the experimental group (EG) or the control group (CG). Data collected will include pre-test SFDPS and SASSS scores for the EG and the CG (collected within 24-hours of admission), and post-test SFDPS and SASSS scores for the EG and CG (collected after 14 days). ANCOVA will be used to analyze the pre-test and post-test data recorded from participants' scores.

Conditions

  • Substance Use Disorders
  • Opiate Dependence
  • Opiate Withdrawal Syndrome
  • Opioid-use Disorder
  • Alcohol Withdrawal
  • Alcohol Abuse
  • Alcohol Use Disorder
  • Cocaine Abuse
  • Cocaine Use Disorder
  • Cocaine Withdrawal
  • Benzodiazepine Abuse
  • Benzodiazepine Dependence
  • Substance Abuse
  • Heroin Overdoses
  • Heroin Withdrawal
  • Heroin Abuse

Interventions

BEHAVIORAL

Six Step Model of Self-Forgiveness

The six-step model includes a workbook that applies Worthington's (2013) conceptualization of self-forgiveness and guides the practitioner and participant through the self-forgiveness process. Each step provides a framework for techniques and includes psychoeducation, interventions, and "homework" to be completed in between sessions. The individual sessions will not conflict with the timing or content of the unit's regular treatment schedule, thus, participation in the study will not affect a patient's ability to participate in TAU. All interventions will be done individually to ensure that participant confidentiality is respected throughout the therapeutic process.

BEHAVIORAL

Treatment as Usual (TAU)

Treatment as Usual (TAU) includes four group therapy sessions facilitated by the social services team (counselors and social workers), two 12-step meetings facilitated by outside representatives of Alcoholics Anonymous (AA) and Narcotics Anonymous (NA), dietary, spirituality, medical care including vital signs and the administration of prescribed medication by the nursing staff, and individual needs assessment with a recommendation of appropriate aftercare.

Sponsors & Collaborators

  • Indiana University of Pennsylvania

    collaborator UNKNOWN
  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Holly P Branthoover, EdD. · Indiana University of Pennsylvania

  • Michael P Verona, MA · Indiana University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2019-12-01
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03971097 on ClinicalTrials.gov